CVM Updates - FDA reissuing draft guidance for human and animal drug manufacturers on Disclosing Risk Information in Consumer-Directed Print Advertisements and Promotional Labeling for Prescription Drugs

["U.S. Food & Drug Administration (FDA)" <fda@xxxxxxxxxxxxxxxxxxxxxxx>]

Title: CVM Updates - FDA reissuing draft guidance for human and animal drug manufacturers on Disclosing Risk Information in Consumer-Directed Print Advertisements and Promotional Labeling for Prescription Drugs

You are subscribed to CVM Updates from the U.S. Food & Drug Administration's (FDA) Center of Veterinary Medicine (CVM).   CVM Updates are brief news releases issued on developments of interest to our stakeholders and the public. 

This information has recently been updated and is now available.

FDA reissuing draft guidance for human and animal drug manufacturers on Disclosing Risk Information in Consumer-Directed Print Advertisements and Promotional Labeling for Prescription Drugs – http://www.fda.gov/AnimalVeterinary/NewsEvents/CVMUpdates/ucm457217.htm

 

 

CVM Updates – http://www.fda.gov/AnimalVeterinary/NewsEvents/CVMUpdates/default.htm

 

Visit our home page at http://www.fda.gov/AnimalVeterinary/default.htm

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? Please visit subscriberhelp.govdelivery.com
• Other inquiries? webmail@xxxxxxxxxx

---

This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420